Get started
Author

R.A.A. Wise

Ensifentrine, a Novel Dual Phosphodiesterase (PDE) 3 and 4 Inhibitor, Improves Lung Function, Symptoms, Quality of Life and Reduces Exacerbation Rate and Risk in the Enhance-1 Phase 3 Trial of Ensifentrine in COPD
2023 · F.C. Sciurba, R.A.A. Wise, et al. · American Journal of Respiratory and Critical Care Medicine · 1
A New Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease
2025 · S.P. Bhatt, E. Abadi, et al. · American Journal of Respiratory and Critical Care Medicine
FEV1Q Is a Race-agnostic Approach to Assessing Lung Function and Predicting Survival
2023 · A. Balasubramanian, R.A.A. Wise, et al. · American Journal of Respiratory and Critical Care Medicine
Estimating Rate of Lung Function Change Using Clinical Spirometry Data
2023 · A. Balasubramanian, C. Cervantes, et al. · American Journal of Respiratory and Critical Care Medicine
Airway Predominant COPDIs Associated With Elevated Risk for Cognitive Impairment in Tobacco Exposed Older Adults
2023 · G.L. Kinney, C. Linkenmeyer, et al. · American Journal of Respiratory and Critical Care Medicine
Somatic Mutations of MUC5B Within Lung Tissue in Idiopathic Pulmonary Fibrosis
2023 · J.H. Yun, M.A.W. Khan, et al. · American Journal of Respiratory and Critical Care Medicine
Classifying Physical Conditioning Using Remote Monitoring in Chronic Obstructive Pulmonary Disease
2023 · A. Balasubramanian, M. French, et al. · American Journal of Respiratory and Critical Care Medicine
Disproportionate Impairment in Diffusing Capacity Is a Predictor of Pulmonary Vascular Resistance in Chronic Obstructive Pulmonary Disease
2023 · A. Balasubramanian, A. Fawzy, et al. · American Journal of Respiratory and Critical Care Medicine
Works count: 8
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type